The Profound Impacts of Precision Medicine, Genomic Sequencing on Cancer Care
Precision Oncology is helping NCI treat cancer based on specific genetic changes in a patient’s tumor by allowing them to target mutations that will lower toxicity and improve overall effectiveness of the treatment.
A clinical trial at the National Cancer Institute called NCI-MATCH showed how cancer patients could benefit from genomic sequencing and is now informing future trials on precision medicine.
The NCI Molecular Analysis for Therapy Choice Trial initially screened 6,000 patients and treated 1,300 of them by pairing certain medications with their specific tumors regardless of the cancer type. Future trials like ComboMATCH will now look at precision medicine to study how tumors respond to targeted treatments.
NCI Researchers Dr. Lindsay Harris and Dr. Peter O’Dwyer shared how precision oncology is expanding treatment options and increasing patients’ survival rates. They also discuss the importance of clinical trials like these for progressing the fight against cancer.
-
Dr. Lyndsay Harris Associate Director, Cancer Diagnosis Program NCI -
Dr. Peter O'Dwyer Group Co-Chair ECOG-ACRIN Cancer Research Group
-
Streamlining the ATO Process Makes Software Deployments More Efficient, Secure
NIST’s Victoria Yan Pillitteri discusses common ATO stumbling blocks and how agencies can streamline authorization for secure software deployment.
7m watch -
This National Lab is Using Multi-Agent AI to Accelerate Scientific Discovery
SLAC’s John Sarrao details how AI is accelerating materials discovery and reshaping collaboration across national labs and federal agencies.
21m watch -
DOT Advisor: Federal Contracting Must Adapt to Keep Pace With AI
AI is advancing faster than federal procurement cycles, making modular contracts, AI disclosure and new pricing models increasingly critical.
11m watch -
NIST Explores AI’s Role in DevSecOps
Michael Ogata discusses NIST’s latest DevSecOps research, the growing role of AI agents and the need for new approaches to identity and authorization.
4m watch
